Zentalis Share Price

Zentalis Share Price

NASDAQ: ZNTL | Micro Cap | Healthcare
$1.38
-$0.12 (-7.69%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Zentalis Stock Performance

Open
$1.50
Prev. Close
$1.50
Circuit Range
N/A
Day Range
$1.36 - $1.52
Year Range
$1.28 - $6.94
Volume
95,514
Average Traded
$1.43

Zentalis Share Price Today

As of 19 November 2026, Zentalis Pharmaceuticals, Inc.'s share price is $1.38. The stock opened at $1.50, compared to its previous close of $1.50. During today's trading session, Zentalis Pharmaceuticals, Inc.'s share price traded between $1.36 and $1.52, with an average price of $1.44. Over the past 52 weeks, the stock has recorded a high of $6.94 and a low of $1.28. In terms of performance, Zentalis Pharmaceuticals, Inc.'s share price has declined by 65.50% over the last six months and is down 3.50% on a year-on-year basis.

Zentalis Share Price Chart

Line chart of the Zentalis price trend over the selected period. The price fell overall, ranging from 1.36 to 1.52, ending at 1.38.
$1.36$1.52
L
Show Current Price
H

Zentalis Stock Fundamentals & Key Indicators

Market Cap
$99.18M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.44
Revenue (TTM)
$0.00
Return On Equity (TTM)
-69.14%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
18.17%

Zentalis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$35.22-$35.35-$42.29-$28.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.37%-19.63%31.85%

Zentalis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$67.43$0.00
Net Profit-$236.81-$292.19-$165.84-$137.06
Net Profit MarginN/AN/A-245.94%N/A
Income ChangeN/A-23.39%43.24%17.35%

Zentalis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets35.7844.2754.9787.38
Current Assets253.19386.07496.72451.93
Total Assets288.97430.34551.69539.31
Non Current Liabilities36.240.4344.9348.64
Current Liabilities36.5652.7369.3756.65
Total Liabilities72.7693.15114.3105.29
Shareholders' Equity216.2337.19437.39434.02

Zentalis Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-125.25-170.86-207.82-163.75
Investing131.62176.56-44.46-114.18
Financing-4.280.11237.3261.04

About Zentalis

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Zentalis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.96
$1.36
-30.00%
Oct 2026
$2.74
$1.95
-29.22%
Sep 2026
$3.70
$2.75
-28.90%
Aug 2026
$4.66
$3.88
-18.16%
Jul 2026
$4.79
$4.74
-2.27%
Jun 2026
$3.99
$4.84
+21.12%
May 2026
$4.00
$4.00
-0.12%
Apr 2026
$2.43
$4.00
+70.43%
Mar 2026
$2.44
$2.35
-1.67%
Feb 2026
$2.42
$2.39
-2.05%
Jan 2026
$1.33
$2.44
+81.41%
Dec 2025
$1.39
$1.34
-5.94%

Zentalis Share Price FAQs